Successful quantification of 4'-methyl-α-pyrrolidinohexanophenone (MPHP) in human urine using LC-TOF-MS in an autopsy

Kaori Shintani-Ishida1, Yasuhiro Kakiuchi1, Hiroshi Ikegaya1

  • 1Department of Forensic Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto, 602-8566 Japan.

Forensic Toxicology
|August 23, 2016
PubMed

Insights

Detecting the synthetic cathinone 4'-methyl-α-pyrrolidinohexanophenone (MPHP) in urine is challenging due to metabolism. This study developed a sensitive method to quantify unmetabolized MPHP in an autopsy case.

Area of Science:

  • Forensic Toxicology
  • Analytical Chemistry
  • Pharmacology

Background:

  • Synthetic cathinones, including 4 -methyl-α-pyrrolidinohexanophenone (MPHP), pose challenges in toxicological analysis.
  • Metabolism of MPHP prior to excretion hinders its detection in biological samples like urine.

Purpose of the Study:

  • To develop and validate a sensitive method for quantifying unmetabolized MPHP in human urine.
  • To apply this method to determine MPHP concentrations in an autopsy case.

Main Methods:

  • Liquid chromatography-time-of-flight-mass spectrometry (LC-TOF-MS) was employed for sensitive MPHP quantification.
  • Method validation included linearity assessment (1.00-100 ng/mL) and determination of the limit of detection (0.5 ng/mL).

Main Results:

  • The developed LC-TOF-MS method demonstrated good linearity and a low limit of detection in human urine.
  • In an autopsy case, unmetabolized MPHP was successfully quantified in urine (60.1 ng/mL), plasma (32.9 ng/mL), and liver tissue (63.1 ng/g).

Conclusions:

  • This study presents a reliable method for detecting unmetabolized MPHP, overcoming previous analytical limitations.
  • The findings are crucial for forensic toxicology, enabling accurate MPHP assessment in post-mortem investigations.

Related Concept Videos